Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€104.86

€104.86

-5.050%
-5.58
-5.050%
€169.78
 
21:59 / Tradegate WKN: 927079 / Symbol: ILMN / Name: Illumina / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Illumina Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Illumina

sharewise wants to provide you with the best news and tools for Illumina, so we directly link to the best financial data sources.

News

Why Illumina Stock Zoomed Higher on Thursday: https://g.foolcdn.com/editorial/images/770227/medical-professional-working-at-a-computer-terminal.jpg
Why Illumina Stock Zoomed Higher on Thursday

A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P

Why Illumina Stock Mashed the Market on Monday: https://g.foolcdn.com/editorial/images/766928/medical-professional-holding-dollar-sign-paperweight.jpg
Why Illumina Stock Mashed the Market on Monday

Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy

Why Illumina Rallied 36.6% in December: https://g.foolcdn.com/editorial/images/760588/scientist-altering-dna-genome-project.jpg
Why Illumina Rallied 36.6% in December

Shares of gene sequencing leader Illumina (NASDAQ: ILMN) rallied 36.6% in December, according to data from S&P Global Market Intelligence.

Investors might not be quite so excited, as Illumina